A detailed history of Curated Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Curated Wealth Partners LLC holds 2,016 shares of ABBV stock, worth $362,880. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,016
Previous 2,027 0.54%
Holding current value
$362,880
Previous $347,000 14.7%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $1,802 - $2,192
-11 Reduced 0.54%
2,016 $398,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $313,759 - $366,400
2,027 New
2,027 $347,000
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $14,172 - $15,961
-103 Reduced 4.57%
2,149 $333,000
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $43,416 - $50,261
-325 Reduced 12.61%
2,252 $335,000
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $31,537 - $39,246
-238 Reduced 8.45%
2,577 $347,000
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $17,931 - $20,650
-124 Reduced 4.22%
2,815 $448,000
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $10,373 - $12,440
75 Added 2.62%
2,939 $475,000
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $5,905 - $6,772
-44 Reduced 1.51%
2,864 $382,000
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $68,947 - $87,654
-501 Reduced 14.7%
2,908 $444,000
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $4,189 - $5,301
39 Added 1.16%
3,409 $461,000
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $14,470 - $16,426
-136 Reduced 3.88%
3,370 $363,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $97,740 - $108,888
929 Added 36.05%
3,506 $394,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $263,627 - $290,221
2,577 New
2,577 $278,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Curated Wealth Partners LLC Portfolio

Follow Curated Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curated Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curated Wealth Partners LLC with notifications on news.